Breakthrough vaccine targets pancreatic cancer cells, showing promise in preclinical trials and paving the way for human testing.

Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer Society.

Rare appendix cancer diagnoses have tripled among millennials and quadrupled in younger Gen X individuals, according to new research published in the Annals of Internal Medicine.

The MRI shows a brain tumor in an inauspicious location, and a brain biopsy will entail high risks for a patient who had consulted doctors due to double vision. Situations such as this case ...

Karla Flores was diagnosed with a rare brain tumor. A misplaced MRI found a second, nearly inoperable, tumor on her spine.

The first patient has received treatment with mavrostobart plus chemo in the phase 1/2 MORNINGSTAR trial for advanced solid tumors, including lung cancer.

Cancer is a health condition in which cells grow uncontrollably, whereas a tumor is an abnormal mass of tissue that develops when cells multiply too quickly.

Prostate cancer is one of the most common types of cancer in the U.S., and often treatable. One urologist says Biden has good options ahead — largely thanks to recent advances in research.

Scientists discover how to rouse the immune system around "cold" tumors, making them vulnerable to cancer-killing immune therapies with checkpoint inhibitors.

A recent study shows how extrachromosomal DNA contributes to tumor heterogeneity and may drive cancer progression.

Learn about phyllodes tumors of the breast, including diagnosis methods, treatment options, and management strategies for this rare fibroepithelial neoplasm.

Circulating tumor DNA (ctDNA) is a novel biomarker to monitor treatment response and predict cancer recurrence. However, the real-world performance of ctDNA monitoring is not well characterized in ...